Lipids from gut microbiota: pursuing a personalized treatment

Area of Science:

• Microbiome research
• Metabolic engineering
• Gastroenterology

Background:

• Fecal transplantation shows therapeutic promise, but pathogenic organism transfer poses infection risks.
• Gut microbiota metabolites, particularly lipids, influence host phenotypes and inflammation.
• Microbiota-derived lipids impact cell signaling and clinical outcomes.

Purpose of the Study:

• To review the role of bioactive gut microbiota-associated lipids in cellular functioning and clinical outcomes.
• To explore the potential of the gut microbiota as a tool for metabolic engineering of lipids.
• To assess the feasibility of using engineered gut microbiota for novel personalized therapies.

Main Methods:

• Literature review focusing on microbiome metabolites and fecal transplantation.
• Analysis of lipid metabolism within the gut microbiota.
• Investigation of cell signaling pathways regulated by microbial lipids.

Main Results:

• Microbiome-derived lipids significantly regulate host cell signaling, including inflammatory pathways.
• Lipids produced by gut microbiota influence host phenotype and clinical outcomes.
• The gut microbiota possesses the capacity for metabolic engineering of lipids.

Conclusions:

• Gut microbiota-associated lipids are key mediators of host-microbe interactions and health.
• Metabolic engineering of the gut microbiota offers a promising avenue for personalized lipid-based therapies.
• Further research is warranted to harness the gut microbiota's biotechnological potential for therapeutic lipid production.